Casdin Partners Master Fund, L.P. Biolife Solutions Inc (BLFS) insider trading activity

Casdin Partners Master Fund, L.P. is > 10% Shareholder of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 8.71 Million shares of BLFS, which is worth approximately $204 Million. The most recent transaction as insider was on Apr 30, 2024, when has been sold 150,000 shares (Common Stock, par value $.001 per share) at a price of $17.54 per share, resulting in proceeds of $2,631,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.71M

0% 3M change

1.75% 12M change

Total Value Held $204 Million

Casdin Partners Master Fund, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 30 2024	BUY Other acquisition or disposition	$2,631,000 $17.54 p/Share	150,000 Added 1.69%	8,707,165 Common Stock, par valu...
Oct 19 2023	BUY Open market or private purchase	$10,374,976 $11.19 p/Share	927,165 Added 9.78%	8,557,165 Common Stock, par valu...
Aug 09 2023	BUY Open market or private purchase	$771,738 $13.2 p/Share	58,465 Added 0.76%	7,630,000 Common Stock, par valu...
Sep 01 2021	BUY Other acquisition or disposition	-	126,185 Added 1.64%	7,566,292 Common Stock, par valu...
Nov 24 2020	BUY Open market or private purchase	$36,000,000 $22.5 p/Share	1,600,000 Added 17.7%	7,440,107 Common Stock, par valu...
Jul 02 2020	BUY Open market or private purchase	$4,430,954 $14.5 p/Share	305,583 Added 4.97%	5,840,107 Common Stock, par valu...
Jul 01 2020	BUY Open market or private purchase	$9,932,500 $14.5 p/Share	685,000 Added 11.01%	5,534,524 Common Stock, par valu...
May 22 2020	BUY Open market or private purchase	$5,000,006 $10.5 p/Share	476,191 Added 8.94%	4,849,524 Common Stock, par valu...
May 14 2020	BUY Open market or private purchase	$20,000,001 $10.5 p/Share	1,904,762 Added 30.34%	4,373,333 Common Stock, par valu...
Nov 20 2019	BUY Open market or private purchase	$313,600 $15.68 p/Share	20,000 Added 0.8%	2,468,571 Common Stock, par valu...
Nov 19 2019	BUY Open market or private purchase	$303,000 $15.15 p/Share	20,000 Added 0.81%	2,448,571 Common Stock, par valu...

Also insider at

DBTX

Decibel Therapeutics, Inc. Healthcare

> 10% Shareholder

VERV

Verve Therapeutics, Inc. Healthcare

> 10% Shareholder

ABSI

Absci Corp Healthcare

Director

MXCT

MAXCYTE, INC. Healthcare

> 10% Shareholder

TNYA

Tenaya Therapeutics, Inc. Healthcare

> 10% Shareholder

LAB

STANDARD BIOTOOLS INC. Healthcare

Director

CPM